Tepotinib safety in MET exon 14 (METex14) skipping NSCLC: Updated results from the VISION trial Meeting Abstract
| Authors: | Veillon, R.; Sakai, H.; Le, X.; Felip, E.; Garassino, M. C.; Cortot, A.; Smit, E.; Park, K.; Griesinger, F.; Britschgi, C.; Wu, Y.; Berghoff, K.; Otto, G.; Bruns, R.; Paik, P. |
| Abstract Title: | Tepotinib safety in MET exon 14 (METex14) skipping NSCLC: Updated results from the VISION trial |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | met inhibitor; tepotinib; met exon 14 skipping |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S231 |
| Language: | English |
| ACCESSION: | WOS:000631349600303 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.152 |
| Notes: | Meeting Abstract: FP14.09 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
